Preclinical Contract Research Orgnization (CRO).
Fast. Focused. Flexible.
MD Biosciences is a contract research organization (CRO) offering preclinical services for efficacy testing, mode of action platforms, in vitro analysis, histology and imaging for the Pharmaceutical, Medical Device and Animal Health & Nutrition Industries. Our experience & focus is within the inflammations, autoimmune, neurology and cardiac disease fields. We can provide you an entire solution for your drug discovery process or ala carte services to supplement your existing resources.
MDB News
MD Biosciences releases Human Collagen Type I ELISA.
MD Biosciences releases Lumican and Keratocan Monoclonal Antibodies for eye/cornea research.
Conferences
World Pharma Congress (June)
Biomed Israel (June)
ACR (Oct)
SfN (Oct)
more conferences...
Newsletter
Sign up to receive Target Inflammation:
an applications newsletter for drug discovery and medical device testing.